Publications prior to the birth of Wang Lab

(2009) The UCSC Cancer Genomics Browser.
Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F, Kuhn R, Karolchik D, Archie J, Lenburg M, Esserman L, Kent J, Haussler D, Wang T.
Nature Methods 2009 Apr;6(4):239-40
(Corresponding author)

(2009) The UCSC Genome Browser Database: update 2009.
Kuhn, RM, Karolchik D, Zweig AS, Wang, T, Smith KE, Rosenbloom KR, Rhead B, Raney BJ, Pohl A, Pheasant M, Meyer L, Hsu F, Hinrichs AS, Harte RA, Giardine B, Fujita P, Diekhans M, Dreszer T, Clawson H, Barber GP, Haussler D, Kent WJ.
Nucleic Acids Res. 2009 Jan; 37:D755-D761

(2008) Genome wide screens in yeast to identify potential binding sites and target genes of DNA-binding proteins.
Zeng J, Yan J, Wang T, Mosbrook-Davis D, Dolan KT, Christensen R, Stormo GD, Haussler D, Lathrop RH, Brachmann RK, Burgess SM.
Nucleic Acids Res. 2008 Jan;36(1):e8. Epub 2007 Dec 17.
( Co-first author)

(2008) The UCSC Genome Browser Database: 2008 update.
Karolchik D, Kuhn RM, Baertsch R, Barber GP, Clawson H, Diekhans M, Giardine B, Harte RA, Hinrichs AS, Hsu F, Kober KM, Miller W, Pedersen JS, Pohl A, Raney BJ, Rhead B, Rosenbloom KR, Smith KE, Stanke M, Thakkapallayil A, Trumbower H, Wang T, Zweig AS, Haussler D, Kent WJ.
Nucleic Acids Res. 2008 Jan;36(Database issue):D773-9. Epub 2007 Dec 17.

(2007) Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53.
Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D
Proc Natl Acad Sci U S A 104:18613-18618 Epub 2007 Nov 14

(2007) Using PhyloCon to Identify Conserved Regulatory Motifs.
Wang T.
Current Protocols in Bioinformatics. 19:2.12.1-2.12.29.

(2006) Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss-of-heterozygosity as an important aspect of p53 status in human cancers.
Dearth LR, Qian H, Wang T, Baroni TE, Zeng J, Chen SW, Yi SY, Brachmann RK
Carcinogenesis. 2006, July 21 [Epub ahead of print].

(2006) Overexpression of the oncoprotein prothymosin alpha triggers a p53 response characterized by p53 acetylation and growth suppression.
Kobayashi T, Wang T, Truong LN, Maezawa M, Kobayashi M, Ohnishi S, Hatanaka K, Hige S, Shimizu Y, Kato M, Asaka M, Tanaka J, Imamura M, Hasegawa K, Tanaka Y, and Brachmann RK
Cancer Res. 2006 Mar 15;66(6):3137-44.

(2006) An improved map of conserved regulatory sites for Saccharomyces cerevisiae.
MacIsaac K, Wang T, Gordon BD, Gifford DK, Stormo GD, Fraenkel E
BMC Bioinformatics. 2006 Mar 7;7(1):113.
(Co-first author)

(2005) Tcf- and Vent-binding sites regulate neural-specific geminin expression in the gastrula embryo.
Taylor JJ, Wang T, Kroll KL
Dev Biol. 2006 Jan 15; 289(2):494-506. Epub 2005 Dec 9.

(2005) Identifying the conserved regulatory networks of a eukaryotic genome.
Wang T, Stormo GD
Proc Natl Acad Sci U S A. 2005 Nov 29; 102(48):17400-5. Epub 2005 Nov 21.

(2004) The gut microbiota as an environmental factor that regulates fat storage.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15718-23.

(2004) RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.
Hu Y, Wang T, Stormo GD, Gordon JI
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5559-64.

(2004) A global suppressor motif for p53 cancer mutants.
Baroni TE, Wang T, Qian H, Dearth LR, Truong LN, Zeng J, Denes AE, Chen SW, and Brachmann RK
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4930-5.
(Co-first author)

(2003) Combining phylogenetic data with co-regulated genes to identify regulatory motifs.
Wang T, and Stormo GD
Bioinformatics 19, 2369-2380.

(2003) Genetic strategies in Saccharomyces cerevisiae to study human tumor suppressor genes.
Kobayashi T, Wang T, Qian H, and Brachmann RK
Methods Mol Biol 223, 73-86.

(2002) Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
Qian H, Wang T, Naumovski L, Lopez CD, and Brachmann RK
Oncogene 21, 7901-7911

(2001) hADA3 is required for p53 activity.
Wang T, Kobayashi T, Takimoto R, Denes AE, Snyder EL, el-Deiry WS, and Brachmann RK
Embo J 20, 6404-6413.